Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions

Study Information

Locations

Not Specified

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

Our objective is to examine “coverage, price, and reimbursement” (“CPR”) for multigene tests broadly and for cancer-related indications, specifically, why tests are covered/not covered by payers, how this is changing over time, and how CPR influences testing decisions and practices in clinic settings.

Prime PI is Kathryn A. Phillips, Ph.D., UCSF. Site PI is Su-Ying Liang, Ph.D.

Principal Investigator

Su-Ying Liang, Ph.D.

Funder

National Institutes of Health - National Cancer Institute

Related Studies

Cancer Liquid Biopsy Monitoring Study

A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung c

Investigators: Mohammed Kashani-Sabet, M.D., Deepti Behl, MD

COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs

Project goals: To understand impacts of COVID-19 on cancer care management (detection, diagnosis, treatment), pt-reported experience, and cancer care costs.

Investigators: Cheryl Stults, Ph.D., Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.

Stupski Serious Illness Program Evaluation

Evaluate palliative care projects at seven healthcare organizations in the SF Bay Area.

Investigator: Sylvia Sudat, PhD

Impact of COVID-19 on Cancer Care Management

Study will enhance understanding of cancer care management due to COVID-19.

Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH

Improving Cancer Care

Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.

Investigator: Su-Ying Liang, Ph.D.

Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)

Provide insights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with LDCT.

Investigator: Jiang Li, Ph.D., MPH

Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts

To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.

Investigators: Monique de Bruin, M.D., MPH, External PI, Principal Investigator, Su-Ying Liang, Ph.D.

Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women

The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.

Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D.

Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care

To examine how EHR data can expand understanding of breast cancer pathways--screening to dx and tx.

Breast Cancer Chemoprevention in Primary Care at Geisinger

Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.

Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator